The general public may not yet need COVID-19 booster doses, according to a new review; a significant incidence of anxiety tied to climate change and government inaction is being reported in young people; COVID-19 infections in US children have increased by approximately 240% since early July.
According to an expert review of scientific evidence on COVID-19 vaccine efficacy published in The Lancet, booster doses were indicated to not be needed for the general public at this time. Reported by CNBC, findings from researchers, which included scientists of the FDA and World Health Organization, show that COVID-19 vaccines in the United States continue to provide highly effective protection against severe disease and hospitalization caused by the Delta variant. Acknowledging that booster shots may be needed at a later date, the researchers said there are risks associated with distributing booster doses too soon, such as potential incidence of myocarditis, which is more common after the second dose of mRNA vaccines.
As reported by ABC News, a study published today in Lancet Planetary Health found a significant incidence of anxiety in young people related to climate change and government handling of such crises. Surveying 10,000 people aged 16 to 25, 45% of respondents said their feelings of climate change negatively affect their daily life and functioning, with 75% also reporting fear of the future. Notably, 58% of young people said governments are betraying them and 61% said governments are not protecting them, the planet, or future generations.
A recent American Academy of Pediatrics study shows that COVID-19 infections in US children has markedly increased, by about 240%, since early July, when kids accounted for 71,726 cases. Reported by CNN, nearly 500,000 new cases of COVID-19 have been reported among children in the last 2 weeks, which comes as students under the age of 12, who are not eligible for vaccination, are beginning in-person classes nationwide. Currently, children account for 29% of all cases reported across the country.
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More